AtriCure, Inc.

NasdaqGM:ATRC Rapporto sulle azioni

Cap. di mercato: US$1.8b

AtriCure Performance dei guadagni passati

Il passato criteri di controllo 0/6

AtriCure ha registrato una crescita degli utili a un tasso medio annuo di 1.2%, mentre il settore Medical Equipment ha registrato utili in crescita a un tasso medio annuo di 13.2%. I ricavi sono stati in crescita a un tasso medio annuo di 16.6%.

Informazioni chiave

1.2%

Tasso di crescita degli utili

5.2%

Tasso di crescita dell'EPS

Medical Equipment Crescita del settore8.9%
Tasso di crescita dei ricavi16.6%
Rendimento del capitale proprio-8.4%
Margine netto-8.7%
Ultimo aggiornamento sui guadagni30 Sep 2024

Aggiornamenti sulle prestazioni recenti

Recent updates

A Piece Of The Puzzle Missing From AtriCure, Inc.'s (NASDAQ:ATRC) 28% Share Price Climb

Nov 06
A Piece Of The Puzzle Missing From AtriCure, Inc.'s (NASDAQ:ATRC) 28% Share Price Climb

US$42.67 - That's What Analysts Think AtriCure, Inc. (NASDAQ:ATRC) Is Worth After These Results

Nov 01
US$42.67 - That's What Analysts Think AtriCure, Inc. (NASDAQ:ATRC) Is Worth After These Results

Is It Time To Consider Buying AtriCure, Inc. (NASDAQ:ATRC)?

Oct 31
Is It Time To Consider Buying AtriCure, Inc. (NASDAQ:ATRC)?

AtriCure, Inc.'s (NASDAQ:ATRC) Intrinsic Value Is Potentially 43% Above Its Share Price

Oct 02
AtriCure, Inc.'s (NASDAQ:ATRC) Intrinsic Value Is Potentially 43% Above Its Share Price

Further Upside For AtriCure, Inc. (NASDAQ:ATRC) Shares Could Introduce Price Risks After 29% Bounce

Sep 06
Further Upside For AtriCure, Inc. (NASDAQ:ATRC) Shares Could Introduce Price Risks After 29% Bounce

Analysts Have Been Trimming Their AtriCure, Inc. (NASDAQ:ATRC) Price Target After Its Latest Report

Aug 02
Analysts Have Been Trimming Their AtriCure, Inc. (NASDAQ:ATRC) Price Target After Its Latest Report

AtriCure's Latest Projects And European Market Entry, Advancing Cardiac Care

Jul 25

AtriCure, Inc. (NASDAQ:ATRC) Soars 26% But It's A Story Of Risk Vs Reward

Jul 18
AtriCure, Inc. (NASDAQ:ATRC) Soars 26% But It's A Story Of Risk Vs Reward

AtriCure, Inc.'s (NASDAQ:ATRC) Intrinsic Value Is Potentially 88% Above Its Share Price

May 30
AtriCure, Inc.'s (NASDAQ:ATRC) Intrinsic Value Is Potentially 88% Above Its Share Price

Positive Sentiment Still Eludes AtriCure, Inc. (NASDAQ:ATRC) Following 29% Share Price Slump

Apr 04
Positive Sentiment Still Eludes AtriCure, Inc. (NASDAQ:ATRC) Following 29% Share Price Slump

Does AtriCure (NASDAQ:ATRC) Have A Healthy Balance Sheet?

Mar 14
Does AtriCure (NASDAQ:ATRC) Have A Healthy Balance Sheet?

Investors Interested In AtriCure, Inc.'s (NASDAQ:ATRC) Revenues

Jan 21
Investors Interested In AtriCure, Inc.'s (NASDAQ:ATRC) Revenues

Is AtriCure (NASDAQ:ATRC) Using Debt In A Risky Way?

Nov 29
Is AtriCure (NASDAQ:ATRC) Using Debt In A Risky Way?

AtriCure, Inc.'s (NASDAQ:ATRC) Intrinsic Value Is Potentially 99% Above Its Share Price

Sep 27
AtriCure, Inc.'s (NASDAQ:ATRC) Intrinsic Value Is Potentially 99% Above Its Share Price

Health Check: How Prudently Does AtriCure (NASDAQ:ATRC) Use Debt?

Aug 02
Health Check: How Prudently Does AtriCure (NASDAQ:ATRC) Use Debt?

AtriCure, Inc.'s (NASDAQ:ATRC) Share Price Matching Investor Opinion

Jun 15
AtriCure, Inc.'s (NASDAQ:ATRC) Share Price Matching Investor Opinion

Is AtriCure (NASDAQ:ATRC) Weighed On By Its Debt Load?

Apr 14
Is AtriCure (NASDAQ:ATRC) Weighed On By Its Debt Load?

Calculating The Intrinsic Value Of AtriCure, Inc. (NASDAQ:ATRC)

Mar 02
Calculating The Intrinsic Value Of AtriCure, Inc. (NASDAQ:ATRC)

What Does AtriCure, Inc.'s (NASDAQ:ATRC) Share Price Indicate?

Feb 09
What Does AtriCure, Inc.'s (NASDAQ:ATRC) Share Price Indicate?

Is AtriCure (NASDAQ:ATRC) Using Debt In A Risky Way?

Dec 28
Is AtriCure (NASDAQ:ATRC) Using Debt In A Risky Way?

Is Now An Opportune Moment To Examine AtriCure, Inc. (NASDAQ:ATRC)?

Sep 06
Is Now An Opportune Moment To Examine AtriCure, Inc. (NASDAQ:ATRC)?

An Intrinsic Calculation For AtriCure, Inc. (NASDAQ:ATRC) Suggests It's 29% Undervalued

Aug 02
An Intrinsic Calculation For AtriCure, Inc. (NASDAQ:ATRC) Suggests It's 29% Undervalued

AtriCure: 5x Sales For A Series Of Impeding Losses? No Thanks

Jun 13

Is AtriCure (NASDAQ:ATRC) Weighed On By Its Debt Load?

Jun 08
Is AtriCure (NASDAQ:ATRC) Weighed On By Its Debt Load?

Ripartizione dei ricavi e delle spese

Come AtriCure guadagna e spende denaro. In base agli ultimi utili dichiarati, su base LTM.


Storia dei guadagni e delle entrate

NasdaqGM:ATRC Ricavi, spese e utili (USD Millions )
DataRicaviGuadagniSpese G+ASpese di R&S
30 Sep 24448-3928782
30 Jun 24430-4027581
31 Mar 24415-3727078
31 Dec 23399-3025874
30 Sep 23381-2524567
30 Jun 23366-2824162
31 Mar 23349-3823559
31 Dec 22330-4623157
30 Sep 22316-5622957
30 Jun 223035322154
31 Mar 222905221451
31 Dec 212745020549
30 Sep 212594519046
30 Jun 21243-5717445
31 Mar 21213-4915143
31 Dec 20207-4815143
30 Sep 20210-4614745
30 Jun 20212-5015745
31 Mar 20230-4616545
31 Dec 19231-3516741
30 Sep 19222-2315937
30 Jun 19216-2015035
31 Mar 19209-1714434
31 Dec 18202-2114035
30 Sep 18195-2013534
30 Jun 18187-2013033
31 Mar 18180-2712634
31 Dec 17175-2712134
30 Sep 17170-3311636
30 Jun 17166-3211137
31 Mar 17160-3410937
31 Dec 16155-3310536
30 Sep 16150-3610634
30 Jun 16143-3510232
31 Mar 16135-329729
31 Dec 15129-279126
30 Sep 15123-228523
30 Jun 15118-168322
31 Mar 15112-147820
31 Dec 14107-167819
30 Sep 1499-167417
30 Jun 1493-186815
31 Mar 1487-176514
31 Dec 1381-115713

Guadagni di qualità: ATRC al momento non è redditizia.

Margine di profitto in crescita: ATRC al momento non è redditizia.


Flusso di cassa libero e analisi degli utili


Analisi della crescita degli utili nel passato

Andamento degli utili: ATRC non è redditizia, ma ha ridotto le perdite negli ultimi 5 anni a un tasso pari a 1.2% all'anno.

Accelerare la crescita: Impossibile confrontare la crescita degli utili di ATRC nell'ultimo anno con la sua media quinquennale poiché al momento non è redditizia

Guadagni vs Settore: ATRC non è redditizia, il che rende difficile confrontare la crescita dei suoi utili dell'anno passato con il settore Medical Equipment ( 12.6% ).


Rendimento del capitale proprio

ROE elevato: ATRC ha un Return on Equity negativo ( -8.37% ), in quanto al momento non è redditizio.


Rendimento delle attività


Rendimento del capitale investito


Scoprire le aziende con forti performance passate